Sciannameo, V.
Berchialla, P.
Avogaro, A.
Fadini, G. P. http://orcid.org/0000-0002-6510-2097
,
Consoli, Agostino
Formoso, Gloria
Grossi, Giovanni
Pucci, Achiropita
Sesti, Giorgio
Andreozzi, Francesco
Capobianco, Giuseppe
Gatti, Adriano
Bonadonna, Riccardo
Zavaroni, Ivana
DeiCas, Alessandra
Felace, Giuseppe
Li Volsi, Patrizia
Buzzetti, Raffaella
Leto, Gaetano
Sorice, Gian Pio
D’Angelo, Paola
Morano, Susanna
Bossi, Antonio Carlo
Duratorre, Edoardo
Franzetti, Ivano
Morpurgo, Paola Silvia
Orsi, Emanuela
Querci, Fabrizio
Boemi, Massimo
D’Angelo, Federica
Petrelli, Massimiliano
Aimaretti, Gianluca
Karamouzis, Ioannis
Cavalot, Franco
Saglietti, Giuseppe
Cazzetta, Giuliana
Cervone, Silvestre
Devangelio, Eleonora
Lamacchia, Olga
Arena, Salvatore
Di Benedetto, Antonino
Frittitta, Lucia
Giordano, Carla
Piro, Salvatore
Rizzo, Manfredi
Chianetta, Roberta
Mannina, Carlo
Anichini, Roberto
Penno, Giuseppe
Solini, Anna
Fattor, Bruno
Bonora, Enzo
Cigolini, Massimo
Lapolla, Annunziata
Chilelli, Nino Cristiano
Simioni, Natalino
Frison, Vera
Vinci, Carmela
Funding for this research was provided by:
Società Italiana di Diabetologia
Article History
Received: 3 March 2021
Accepted: 6 May 2021
First Online: 10 May 2021
Declarations
:
: The study protocol was approved by the ethical committee of the coordinating Center and approved by local ethics committees of all participating centres. Based on national regulations on retrospective studies with anonymous data, patients’ informed consent was waived.
: Not applicable for this manuscript.
: AA received research grants, lecture or advisory board fees from: Merck Sharp & Dome, AstraZeneca, Novartis, Boehringer-Ingelheim, Sanofi, Mediolanum, Janssen, Novo Nordisk, Lilly, Servier, and Takeda. GPF received grants, honoraria or lecture fees from Abbott, Astrazeneca, Boehringer, Lilly, Novo Nordisk, Sanofi. VS and PB have nothing to disclose.